SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-22-063655
Filing Date
2022-03-03
Accepted
2022-03-03 07:55:29
Documents
3

Document Format Files

Seq Description Document Type Size
1 POS AM d308362dposam.htm POS AM 324895
2 EX-23.1 d308362dex231.htm EX-23.1 1797
3 GRAPHIC g308362g04b38.jpg GRAPHIC 45492
  Complete submission text file 0001193125-22-063655.txt   386533
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Filer) CIK: 0001680581 (see all company filings)

IRS No.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-260754 | Film No.: 22706769
SIC: 2834 Pharmaceutical Preparations